Breast cancer

2 currently open clinical trials
Palbociclib for patients with hormone receptor positive / HER2-negative breast cancer that has recurred after surgical removal (POLAR)
IBCSG 59-19 POLAR
To reduce the use of Chemotherapy in elderly patients with ER-positive and HER2-positive breast cancer
IBCSG 55-17 TOUCH
All cancer types